Skip to main content
Equibles

BDMD · Baird Medical Investment Holdings Ltd

Track BDMD — free

Use BDMD with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BDMD.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.10 +0.02 (+1.85%) At close · Sep 11
Rebalance outlook locked
Market Cap
$35.18M
Shares
31.98M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$1.10 Open$1.08 Day$1.08–1.14 52W close$0.77–3.44 Avg vol 30d46K Short int35K · 0.1% float · 1.0d Short vol9% DataDec 2021–Sep 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
-39.2%
Year over year
Operating margin
-113.7%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+27.3%
Year over year · more shares
Price change (1Y)
-56.0%
Trailing year
Short interest
0.1%
Latest settlement · 1.0 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Poor Quant / Vol Very High
Market backdrop VIX 15.8 · calm Equity put/call 0.58
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −25%
below
Price vs 50-day avg −2%
below
RSI (14) 47
neutral
MACD trend Negative
52-week position 12%
near low
Momentum
relative strength
Very Weak
1-month return −4%
trailing
6-month return −45%
trailing
YTD return −19%
this year
Relative strength −63%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow Flat
0% holders QoQ · +5 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.11% of float · ▲ +42.3% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
35 holders — near 1-yr low, contrarian setup
Squeeze score 35
low risk · 0–100
Fundamentals
Poor
Revenue growth −39%
Y/Y
Gross margin 84%
contracting
EPS growth −272%
Y/Y
Free cash flow $-1.4M
Balance sheet $8.5M
net debt
Quant / Vol
risk profile
Very High
Volatility 118%
annualized · 1-yr
Max drawdown −72%
past year
ATR 9.1%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
3 · 3 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−25% Bearish
Price vs 50-day avg
−2% Neutral
RSI (14)
47 Neutral
MACD trend
Negative Bearish
52-week position
12% Bearish
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross) No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow Flat
0% holders QoQ · +5 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.11% of float · ▲ +42.3% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
35 holders — near 1-yr low, contrarian setup
Price context
position in its 52-week range
Range low $1 Now $1 · 12% Range high $3
vs 200-day avg -25% vs 50-day avg -2%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Medical Devices — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
BDMD
Baird Medical Investment Holdings Ltd
this stock
$35.18M -19.1% -39.2% — 0.1%
ABT
Abbott Laboratories
 $177.58B -18.6% +5.7% 28.6 1.3%
MDT
Medtronic plc
 $116.35B -5.3% +8.4% 22.4 0.9%
SYK
Stryker Corp
 $105.70B -21.6% +11.2% 28.6 2.0%
BSX
Boston Scientific Corp
 $62.29B -54.9% +12.5% 17.4 3.3%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
35
% held
18.1%
Net QoQ
-577.0K sh
Top holder
Clear Street Group Inc.
Held Float
View
Short & Settlement
Short Interest Rising
Shares short
34.6K
Days to cover
1.0d
Change
+10.3K sh
View
Short Volume
Short vol %
9%
As of
Sep 11, 2026
Short Total
View
Fails to Deliver
FTD shares
44
Value
$50
As of
Aug 14, 2026
View
Off-Exchange
Off-exchange %
65.8%
Week of
Aug 3, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$22.5M
Net income (FY)
$-27.3M
EPS diluted
$-0.98
View
Filings
SEC Filings
Latest
6-K
Filed
Sep 3, 2026
This year
4
View

Performance

5D 20D 120D MTD YTD
BDMD -6.0% -3.5% -44.7% +0.0% -19.1%
SPY -1.2% -1.8% +17.8% -0.4% +12.1%
vs SPY -4.8% -1.8% -62.6% +0.4% -31.2%
Key facts CIK 1982444 CUSIP G0705H103 13F (30d) 1 filings 1 filers Visit website Investor relations